U.S. Markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
12.13+0.08 (+0.66%)
At close: 4:00PM EDT
People also watch
GNVCCRISIMMUBCRXLJPC
  • C
    Cindy
    Cindy
    Kinkeys hysterical taunts to the former novices of this board are not needed here.Two points she made are valid
    1) Insmed no longer has the short stature approval as the manufactured drug no longer exists
    2) Multi year and deep investment make it unlikely anyone can or will risk another failure.Iplex failed a multiple of trials ALS was the last hope for Insmed Shire may use Retinopathy of prematurity indication as pipeline filler but they and others understand the above. Insmed is all about Arikayce and nothing else
  • C
    Cindy
    Cindy
    Try this one here:The @realTrump stock market. Busines has booked.Sept will see a major market downturn allowing this stock to be positioned where ever the new buyer may want. The price will disappoint those who held. It will begin with the debt ceiling and end with -------- constructive replies only Please
  • K
    Kinky
    Kinky
    300 Million! ! \some moron posts stupid and the weasels follow, IPLEX! when all else fails! post about a drug that hasn't been mfg for 9 years Is not being trialed\Insmed has NO APPROVED iplex indication because the drug is no longer valid ( mfg expired). min of 2-3 years would be needed to get the new manufactured drug FDA approval\but they dont know this \Who would post Lies about this company pretending to have a drug iplex?\idiotinvestor village
  • Z
    Zorro
    Zorro
    2nd quarter numbers =Increased Positions 67 4,889,844
    Decreased Positions 41 2,934,744
    Held Positions 17 51,177,882
    Total Institutional Shares 125 59,002,470
    I agree this was all before the attack
  • P
    Predict
    Predict
    So does retail lose and the big time money make a fortune?Are those free options 10x more valuable then any stock management may own? Are they willing to take a cheap takeover price to a large pharma? If the results were reported tomorrow would the stock shoot up 50% to $18? Biotech has scrwd me again
  • l
    linda
    linda
    Anyone have any buys by the top Institutions SINCE June 30? Why haven't they added?
  • P
    Predict
    Predict
    June 30th data .The second quarter had buyers in the $17 to $18 dollar range.The sellers came 2 months later. what changed?Listen to Insmeds last presentation.W.Lewis and every one in management couched their comments in caution IF hope etc. I dont buy conspiracy theories.
  • K
    Kinky
    Kinky
    The poor idiotvillage investors don't get why Sales jobs are not hires\ THEY ARE CONTINGENT ON GETTING AN APPROVED DRUG TO SELL \hopefully by eoy 2018
  • F
    Fghyujk Sdfghj
    Fghyujk Sdfghj
    Traders had fun yesterday with "President Trump to visit Insmed headquarters!
    With the Trump golf course close by and Trumps current residence in Bridgewater N.J a great photo opp and a great chance to unload every single share
  • J
    Joe West
    Joe West
    It's not Manipulation! There are definite sellers.
    INSM top Institutional holder sold 5 % of their holdings on Friday in one day.A lot of second quarter sellers also
    Looks to be setting up for a not so great result JMHO I hope not I own too much
  • A
    Ashley
    Ashley
    In the short-term INSM does not seem to be like a good trade. Ive been struggling with this stock lately. Some of my other trades have been from awe-some*sto-cks which are working out pretty well.
  • K
    Kinky
    Kinky
    Register your complaint with the SEC today! LOL for what? !\ investorvillage squirrels
  • J
    Jennifer
    Jennifer
    My guess is that INSM is due for a pullback in the short-run. awe-some*sto-cks just allerted a new stock - it beats having to dig online yourself for new stock ideas.
  • l
    linda
    linda
    So today is a good day?Volume seems to be drying up but are they finished?Painful for longs.Some mention of 2nd Quarter activity but that was 6 weeks ago+ $17.25 -18. Are the biggest owners of Insmed planning a dilution down here again? A placement could be done to only "strategic owners" {2/3rds owed by just 6 funds}
  • t
    tom
    tom
    Linda is a loser. Will have to turn to hooking!
  • K
    Kinky
    Kinky
    $11.54 please
  • K
    Kinky
    Kinky
    Why do all analst recc the price that I sold at 2 years ago and then went short to the price we are at now? \Coincidence?\ I think not
  • Z
    Zorro
    Zorro
    So its a plot if there is a big seller who thinks the trials may be bad and is dumping?
    There is a seller and the shares are real IV is full of idiots Stop posting about them
  • K
    Kinky
    Kinky
    Google Linhaliq +NTM \which is the better short term trade for a double?\ INSM or ARDM \after a sell on the news ARDM is up 40% in the last 2 weeks
  • K
    Kinky
    Kinky
    ARDM -FDA GIVES OK TO FILE AFTER REVIEWING THEIR PHASE3 TRIAL UP 18% INVESTORS PILING IN announced it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic lung infections with Pseudomonas aeruginosa (P. aeruginosa).